Nanoliposomal Irinotecan in the Clinical Practice Guideline for Metastatic Pancreatic Cancer: Applicability to Clinical Situations Reply

被引：0
|
作者：
Sohal, Davendra P. S. [1 ]
Mangu, Pamela B. [2 ]
Laheru, Daniel [3 ]
Khorana, Alok A. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Amer Soc Clin Oncol, Alexandria, VA USA
[3] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2016.70.7463
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：690 / +
页数：2
相关论文
共 50 条
  • [41] SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
    R. Vera
    E. Dotor
    J. Feliu
    E. González
    B. Laquente
    T. Macarulla
    E. Martínez
    J. Maurel
    M. Salgado
    J. L. Manzano
    Clinical and Translational Oncology, 2016, 18 : 1172 - 1178
  • [42] In reply: Comment on: Canadian clinical practice guideline on brain death
    Shemie, Sam D.
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2023, 70 (12): : 2015 - 2015
  • [43] Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer
    Chiang, Nai-Jung
    Chang, Jang-Yang
    Shan, Yan-Shen
    Chen, Li-Tzong
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (10) : 1413 - 1420
  • [44] Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial
    Bockorny, Bruno
    Macarulla, Teresa
    Semenisty, Valerya
    Borazanci, Erkut
    Feliu, Jaime
    Ponz-Sarvise, Mariano
    Abad, David Gutierrez
    Oberstein, Paul
    Alistar, Angela
    Munoz, Andres
    Geva, Ravit
    Guillen-Ponce, Carmen
    Fernandez, Mercedes Salgado
    Peled, Amnon
    Chaney, Marya
    Gliko-Kabir, Irit
    Shemesh-Darvish, Liron
    Ickowicz, Debby
    Sorani, Ella
    Kadosh, Shaul
    Vainstein-Haras, Abi
    Hidalgo, Manuel
    CLINICAL CANCER RESEARCH, 2021, 27 (18) : 5020 - 5027
  • [45] Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Cervantes, A.
    Adam, R.
    Rosello, S.
    Arnold, D.
    Normanno, N.
    Taieb, J.
    Seligmann, J.
    De Baere, T.
    Osterlund, P.
    Yoshino, T.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2023, 34 (01) : 10 - 32
  • [46] Japanese Clinical Practice Guideline for Head and Neck Cancer
    Nibu, Ken-ichi
    Hayashi, Ryuichi
    Asakage, Takahiro
    Ojiri, Hiroya
    Kimata, Yoshihiro
    Kodaira, Takeshi
    Nagao, Toshitaka
    Nakashima, Torahiko
    Fujii, Takashi
    Fujii, Hirofumi
    Homma, Akihiro
    Matsuura, Kazuto
    Monden, Nobuya
    Beppu, Takeshi
    Hanai, Nobuhiro
    Kirita, Tadaaki
    Kamei, Yuzuru
    Otsuki, Naoki
    Kiyota, Naomi
    Zenda, Sadamoto
    Omura, Ken
    Omori, Koichi
    Akimoto, Tetsuo
    Kawabata, Kazuyoshi
    Kishimoto, Seiji
    Kitano, Hiroya
    Tohnai, Iwai
    Nakatsuka, Takashi
    AURIS NASUS LARYNX, 2017, 44 (04) : 375 - 380
  • [47] Management of Depression in Patients With Cancer: A Clinical Practice Guideline
    Li, Madeline
    Kennedy, Erin B.
    Byrne, Nelson
    Gerin-Lajoie, Caroline
    Katz, Mark R.
    Keshavarz, Homa
    Sellick, Scott
    Green, Esther
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (08) : 747 - +
  • [48] Clinical practice guideline on bladder cancer(Part I)
    Xiying Dong
    Gang Song
    Kaopeng Guan
    Tie Wang
    Xiaoli Feng
    Yulin Liu
    Min Liu
    Zhigang Ji
    Xiao Li
    Jiongming Li
    Yong Zhang
    Fangjian Zhou
    Aiping Zhou
    Wanhai Xu
    Tao Xu
    Xianshu Gao
    Qing Zhai
    Qiang Wei
    Nianzeng Xing
    Uroprecision, 2023, 1 (01) : 20 - 30
  • [49] Appraisal of Clinical Practice Guideline: Exercise for people with cancer
    da Silva, Tatiane
    JOURNAL OF PHYSIOTHERAPY, 2018, 64 (02) : 127 - 127
  • [50] SOCIAL RESTRICTIONS IN CHILDREN WITH CANCER: A CLINICAL PRACTICE GUIDELINE
    Stavleu, Debbie
    Mulder, Renee
    Kruimer, Demi
    Kremer, Leontien
    Tissing, Wim
    Loeffen, Erik
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S384 - S384
12345